NorthRock Partners’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,048
Closed -$253K 693
2025
Q4
$253K Sell
3,048
-6,296
-67% -$471K ﹤0.01% 512
2025
Q3
$627K Buy
9,344
+1,289
+16% +$93.2K 0.01% 468
2025
Q2
$628K Buy
8,055
+414
+5% +$31.7K 0.02% 343
2025
Q1
$585K Buy
7,641
+799
+12% +$65K 0.02% 315
2024
Q4
$526K Buy
6,842
+33
+0.5% +$2.58K 0.02% 344
2024
Q3
$526K Buy
6,809
+542
+9% +$40.4K 0.02% 360
2024
Q2
$426K Buy
6,267
+1,368
+28% +$92.7K 0.02% 381
2024
Q1
$359K Buy
4,899
+352
+8% +$26.9K 0.01% 438
2023
Q4
$343K Buy
+4,547
New +$314K 0.01% 426

Other funds holding CTSH

NorthRock Partners's CTSH Position: Q1 2026 in Review

NorthRock Partners sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 3,048 shares — an estimated $253K sold.

NorthRock Partners first reported a position in CTSH in Q4 2023 and held it in 9 quarters. The position peaked at $628K in Q2 2025. 990 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

  • NorthRock Partners reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
  • NorthRock Partners sold 3,048 Cognizant shares in Q1 2026, an estimated $253K.
  • NorthRock Partners first reported a position in Cognizant in Q4 2023 and held it in 9 quarters.
  • NorthRock Partners's Cognizant position peaked at $628K in Q2 2025.
  • 990 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.